Making Proteins To Fight Cancer
An approach to treating intestine cancer is being developed by Russian researchers from the Bioengineering Centre, Russian Academy of Sciences, under Anna Prokhorchuk’s guidance jointly with American colleagues sponsored by the international CRDF foundation and the Federal Agency for Science and Innovation (Rosnauka).
Any cancerous disease changes the genetic landscape – some genes are suppressed, others get activated, which results in tumour growth, the formation of metastases, and cancer spreads beyond immune system control. The universal mechanism which regulates genes’ activity is DNA methylation, where a methyl group is joined to a certain section of a molecule. Special methyl-DNA binding proteins come into action, bound with a section of the methylated DNA and this suppresses gene activity. The researchers are interested in one of such proteins named Kaiso. They assume that this protein plays an important role in the intestine cancer development, and it can be used for diagnostics and treatment.
First, the researchers measured the level of expression of the Kaiso protein gene in intestinal tumours in mice and in human patients. The level of expression turned out to be dozens of times higher than that in healthy organs and tissues. ‘Kaiso-zero’ mice were then used which were found to be resistant to cancer. The same resistance to cancer was acquired by mice whose DNA methylation had been suppressed by other methods.
As the Kaiso protein content in the majority of human tumours is much higher than that in healthy tissues, it can be potentially used for early detection of cancer. Contemporary molecular methods allow to analyze expression of dozens of genes in the cancerous growth tissues and to compare the obtained picture with the “gene portrait” of normal cells. Certainly, the Kaiso gene is not the only one that can be used for such diagnosticums. The tumour represents a very heterogeneous and rather dynamic system, which requires knowledge of almost the entire “genetic portrait” of 28,000 genes.
It is thought that there are other between 10 and 30 key genes which can also serve as markers of tumour characteristics. This will save resources and time, relieving the necessity of analyzing the entire multithousand genome.
In cancer therapy, chimeric Kaiso protein could be created. The ordinary Kaiso protein (via DNA methylated binding) inhibits the work of cancer suppressor genes. However, it is possible, using the same properties of the protein, to make it not suppress, but reinforce the work of these genes. This is what the researchers are striving to achieve. “Although, there are hidden pitfalls here,” explains Anna Prokhorchuk, project manager. “It is necessary to make chimeric Kaiso work only to activate cancer suppressor genes, not the other methylated DNA sequences. This is what we are working at in the Bioengineering Centre jointly with American colleagues.” The ultimate aim of the investigation is to scrutinize the possibility for using Kaiso protein as a target for directional anticancer therapy.
Sergey Komarov | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...